Oracle Investment Management Inc Top Holdings and 13F Report (2025) About Oracle Investment Management IncInvestment ActivityOracle Investment Management Inc has $183.67 million in total holdings as of December 31, 2024.Oracle Investment Management Inc owns shares of 19 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 20.97% of the portfolio was purchased this quarter.About 17.68% of the portfolio was sold this quarter.This quarter, Oracle Investment Management Inc has purchased 22 new stocks and bought additional shares in 6 stocks.Oracle Investment Management Inc sold shares of 5 stocks and completely divested from 6 stocks this quarter.Largest Holdings GeneDx $78,663,750Biohaven $31,813,610SELECT SECTOR SPDR TR $15,820,550Ardelyx $10,593,415SpringWorks Therapeutics $9,204,948 Largest New Holdings this Quarter SELECT SECTOR SPDR TR $15,820,550 HoldingTELADOC HEALTH INC $2,706,093 HoldingSPRINGWORKS THERAPEUTICS INC $2,016,054 Holding Largest Purchases this Quarter SELECT SECTOR SPDR TR 115,000 shares (about $15.82M)SpringWorks Therapeutics 220,573 shares (about $7.97M)Biohaven 146,520 shares (about $5.47M)Ardelyx 720,231 shares (about $3.65M)TELADOC HEALTH INC 297,700 shares (about $2.71M) Largest Sales this Quarter Phathom Pharmaceuticals 604,423 shares (about $4.91M)BIOHAVEN LTD 102,700 shares (about $3.84M)GeneDx 22,300 shares (about $1.71M)Pacific Biosciences of California 448,239 shares (about $820.28K)NOVAVAX INC 68,600 shares (about $551.54K) Sector Allocation Over TimeMap of 500 Largest Holdings ofOracle Investment Management Inc Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorWGSGeneDx$78,663,750$1,713,978 ▼-2.1%1,023,46842.8%MedicalBHVNBiohaven$31,813,610$5,472,522 ▲20.8%851,77017.3%MedicalSELECT SECTOR SPDR TR$15,820,550$15,820,550 ▲New Holding115,0008.6%PUTARDXArdelyx$10,593,415$3,651,571 ▲52.6%2,089,4315.8%MedicalSWTXSpringWorks Therapeutics$9,204,948$7,969,302 ▲645.0%254,7735.0%MedicalBIOHAVEN LTD$7,470,000$3,835,845 ▼-33.9%200,0004.1%CALLQDELQuidelOrtho$5,269,8640.0%118,2912.9%MedicalBCRXBioCryst Pharmaceuticals$4,027,3960.0%535,5582.2%MedicalNOVAVAX INC$3,746,640$551,544 ▼-12.8%466,0002.0%CALLARDELYX INC$2,964,429$783,315 ▲35.9%584,7001.6%CALLFORAForian$2,814,180$20,600 ▲0.7%1,366,1071.5%MedicalTELADOC HEALTH INC$2,706,093$2,706,093 ▲New Holding297,7001.5%CALLPALANTIR TECHNOLOGIES INC$2,155,455$75,630 ▲3.6%28,5001.2%CL ACAVACAVA Group$2,098,0800.0%18,6001.1%Retail/WholesaleSPRINGWORKS THERAPEUTICS INC$2,016,054$2,016,054 ▲New Holding55,8001.1%CALLPHATPhathom Pharmaceuticals$1,177,920$4,907,916 ▼-80.6%145,0640.6%MedicalPACBPacific Biosciences of California$511,738$820,278 ▼-61.6%279,6380.3%MedicalBIIBBiogen$368,8430.0%2,4120.2%MedicalEYPTEyePoint Pharmaceuticals$242,1250.0%32,5000.1%MedicalSPDR SER TR$0$9,880,000 ▼-100.0%00.0%CALLMYGNMyriad Genetics$0$3,683,955 ▼-100.0%00.0%MedicalPHATHOM PHARMACEUTICALS INC$0$3,484,016 ▼-100.0%00.0%CALLEYEPOINT PHARMACEUTICALS INC$0$2,796,500 ▼-100.0%00.0%CALLPALANTIR TECHNOLOGIES INC$0$744,000 ▼-100.0%00.0%CALLBDSXBiodesix$0$51,470 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
